Loading company…
Hong Kong-based Pathway Pharmaceuticals develops targeted cancer therapies and is led by CEO Anton Buzdin.
Pathway Pharmaceuticals is a pharmaceutical company headquartered in Hong Kong that develops targeted therapies for cancer. Anton Buzdin is CEO. In April 2014 it raised an undisclosed amount in Seed funding from Deep Knowledge Ventures, and it has completed one deal to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in